11:45 AM EDT, 05/21/2025 (MT Newswires) -- Akoya Biosciences ( AKYA ) said in a Wednesday filing that it received an unsolicited acquisition proposal from an undisclosed third party, which offered $1.40 in cash for each Akoya common share.

The company said its board is reviewing the proposal and has determined that it could lead to a superior proposal as defined under its merger deal with Quanterix ( QTRX ) . Akoya said that there is no guarantee that it would constitute a superior proposal following the review.

Quanterix ( QTRX ) and Akoya Biosciences ( AKYA ) announced their updated merger agreement in April, under which Quanterix ( QTRX ) will issue about 7.76 million shares and pay $20 million in cash to Akoya shareholders.

Akoya said its board continues to recommend the merger deal with Quanterix ( QTRX ) to its shareholders.

Shares of Akoya Biosciences ( AKYA ) were up over 25% in recent Wednesday trading.

Price: 1.33, Change: +0.27, Percent Change: +25.38